ITB-02

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameITB-02
Drug Alias Nameindol derivative (National Taiwan University)ITB-02
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsAngiogenesis disorderNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Taiwan University
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAngiogenesis disorderNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A